Carmel Harrington on butyrylcholinesterase as a potential biomarker for SIDS
eBioMedicine in conversation with - A podcast by The Lancet Group
Categorie:
Dr Carmel Harrington joins eBioMedicine to discuss about their findings of a potential biomarker for sudden infant death syndrome. Read the full article: Butyrylcholinesterase is a potential biomarker for Sudden Infant Death Syndrome Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
